These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15649728)

  • 1. Effects of three months of low molecular weight heparin (dalteparin) treatment after bypass surgery for lower limb ischemia--a randomised placebo-controlled double blind multicentre trial.
    Jivegård L; Drott C; Gelin J; Groth O; Hensäter M; Jensen N; Johansson G; Konrad P; Lindberg B; Lindhagen A; Lundqvist B; Oden A; Smith L; Stenberg B; Thornell E; Wingren U; Ortenwall P
    Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):190-8. PubMed ID: 15649728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight heparin for treatment of acute myocardial infarction (FAMI): Fragmin (dalteparin sodium) in acute myocardial infarction.
    Kakkar VV; Iyengar SS; De Lorenzo F; Hargreaves JR; Kadziola ZA;
    Indian Heart J; 2000; 52(5):533-9. PubMed ID: 11256775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers.
    Kalani M; Silveira A; Blombäck M; Apelqvist J; Eliasson B; Eriksson JW; Fagrell B; Torffvit O; Hamsten A; Jörneskog G
    Thromb Res; 2007; 120(5):653-61. PubMed ID: 17275886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of carbon-impregnated and standard ePTFE prostheses in extra-anatomical anterior tibial artery bypass: a prospective randomized multicenter study.
    Kapfer X; Meichelboeck W; Groegler FM
    Eur J Vasc Endovasc Surg; 2006 Aug; 32(2):155-68. PubMed ID: 16617028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does an adjuvant AV-fistula improve the patency of a femorocrural PTFE bypass with distal vein cuff in critical leg ischaemia?--a prospective randomised multicentre trial.
    Laurila K; Lepäntalo M; Teittinen K; Kantonen I; Forssell C; Vilkko P; Nielsen OM; Railo M; Lehtola A;
    Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):180-5. PubMed ID: 14718901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency.
    Hockings BE; Ireland MA; Gotch-Martin KF; Taylor RR
    Med J Aust; 1993 Sep; 159(6):376-8. PubMed ID: 8377686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin).
    Dahl OE; Andreassen G; Aspelin T; Müller C; Mathiesen P; Nyhus S; Abdelnoor M; Solhaug JH; Arnesen H
    Thromb Haemost; 1997 Jan; 77(1):26-31. PubMed ID: 9031444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparity in outcomes of surgical revascularization for limb salvage. Race and gender are synergistic determinants of vein graft failure and limb loss. Nguyen LL, Hevelone N, Rogers SO, Bandyk DF, Clowes AW, Moneta GL, Lipsitz S, Conte MS. Circulation. 2009; 119: 123-130.
    Kreatsoulas C; Anand SS
    Vasc Med; 2009 Nov; 14(4):397-9. PubMed ID: 19808727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety and efficacy of dalteparin administration for elective percutaneous interventions in patients pre-treated with aspirin and ticlopidine].
    Dudek D; Chyrchel M; Legutko J; Bartuś S; Rzeszutko L; Dubiel JS
    Przegl Lek; 2004; 61(12):1301-4. PubMed ID: 15850317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy.
    Wickham L; Bunce C; Wong D; McGurn D; Charteris DG
    Ophthalmology; 2007 Apr; 114(4):698-704. PubMed ID: 17398320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).
    Kakkar AK; Levine MN; Kadziola Z; Lemoine NR; Low V; Patel HK; Rustin G; Thomas M; Quigley M; Williamson RC
    J Clin Oncol; 2004 May; 22(10):1944-8. PubMed ID: 15143088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of 82 patients with diabetic lower limb ischemia by distal arterial bypass.
    Gu YQ; Zhang J; Qi LX; Yu HX; Li JX; Li XF; Guo LR; Luo T; Cui SJ; Wang ZG
    Chin Med J (Engl); 2007 Jan; 120(2):106-9. PubMed ID: 17335650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease.
    Oldgren J; Fellenius C; Boman K; Jansson JH; Nilsson TK; Wallentin L; Siegbahn A
    J Intern Med; 2005 Nov; 258(5):420-7. PubMed ID: 16238677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals.
    Oldgren J; Johnston N; Siegbahn A
    Am Heart J; 2008 Mar; 155(3):493.e1-8. PubMed ID: 18294482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical vein versus heparin-bonded polyester for femoro-popliteal bypass: 5-year results of a prospective randomized multicentre trial.
    Scharn DM; Dirven M; Barendregt WB; Boll AP; Roelofs D; van der Vliet JA
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):61-7. PubMed ID: 17936036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience with a new method of external polyester scaffolding for infrainguinal vein grafts.
    Arvela E; Kauhanen P; Albäck A; Lepäntalo M; Neufang A; Adili F; Schmitz-Rixen T;
    Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):456-62. PubMed ID: 19564122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis for acute lower limb ischaemia--a prospective, randomised, multicentre study comparing two strategies.
    Plate G; Jansson I; Forssell C; Weber P; Oredsson S
    Eur J Vasc Endovasc Surg; 2006 Jun; 31(6):651-60. PubMed ID: 16427339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoropolymer-coated dacron versus PTFE grafts for femorofemoral crossover bypass: randomised trial.
    Eiberg JP; Røder O; Stahl-Madsen M; Eldrup N; Qvarfordt P; Laursen A; Greve M; Flörenes T; Nielsen OM; Seidelin C; Vestergaard-Andersen T; Schroeder TV
    Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):431-8. PubMed ID: 16807001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
    DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.